TRIPOLI, Giada
 Distribuzione geografica
Continente #
NA - Nord America 6.973
EU - Europa 4.846
AS - Asia 3.299
Continente sconosciuto - Info sul continente non disponibili 879
SA - Sud America 553
AF - Africa 94
OC - Oceania 33
Totale 16.677
Nazione #
US - Stati Uniti d'America 6.732
IT - Italia 1.857
SG - Singapore 1.171
RU - Federazione Russa 1.001
CN - Cina 751
DE - Germania 591
BR - Brasile 420
HK - Hong Kong 333
GB - Regno Unito 289
VN - Vietnam 275
FR - Francia 226
BD - Bangladesh 225
PL - Polonia 225
FI - Finlandia 153
CA - Canada 142
JP - Giappone 106
IE - Irlanda 95
IN - India 80
NL - Olanda 76
KR - Corea 73
TR - Turchia 65
ES - Italia 55
AR - Argentina 43
IQ - Iraq 41
SE - Svezia 36
AT - Austria 34
UA - Ucraina 33
RO - Romania 32
MX - Messico 31
AU - Australia 29
ZA - Sudafrica 27
BE - Belgio 21
GR - Grecia 21
CH - Svizzera 20
CO - Colombia 19
EC - Ecuador 17
JM - Giamaica 17
MT - Malta 17
PK - Pakistan 17
SA - Arabia Saudita 17
CL - Cile 16
VE - Venezuela 16
AE - Emirati Arabi Uniti 14
CR - Costa Rica 14
IR - Iran 13
TW - Taiwan 13
CI - Costa d'Avorio 12
ID - Indonesia 12
JO - Giordania 12
MY - Malesia 12
KE - Kenya 11
UZ - Uzbekistan 11
LT - Lituania 9
MA - Marocco 9
PY - Paraguay 9
BG - Bulgaria 8
HN - Honduras 8
PH - Filippine 8
DZ - Algeria 7
TT - Trinidad e Tobago 7
CZ - Repubblica Ceca 6
EG - Egitto 6
EU - Europa 6
HU - Ungheria 6
KZ - Kazakistan 6
LB - Libano 6
NO - Norvegia 6
PT - Portogallo 6
RS - Serbia 6
TN - Tunisia 6
UY - Uruguay 6
NI - Nicaragua 5
NP - Nepal 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
AL - Albania 4
BO - Bolivia 4
AZ - Azerbaigian 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
IL - Israele 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PE - Perù 3
SM - San Marino 3
DK - Danimarca 2
ET - Etiopia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
MM - Myanmar 2
NE - Niger 2
OM - Oman 2
PR - Porto Rico 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 15.783
Città #
Ashburn 1.116
Singapore 784
San Jose 597
Fairfield 570
Chandler 410
Palermo 402
Hong Kong 308
Houston 239
Woodbridge 219
Wilmington 216
Seattle 210
Zgierz 199
Rome 168
Cambridge 163
Beijing 162
Council Bluffs 154
Ann Arbor 152
Moscow 142
Dallas 141
Medford 119
Los Angeles 114
Ho Chi Minh City 103
Tokyo 97
Lauterbourg 95
New York 93
Dublin 90
Boardman 81
Des Moines 78
Milan 75
The Dalles 74
Princeton 71
Santa Clara 70
Altamura 69
Hefei 68
Hanoi 60
London 58
Buffalo 57
Lappeenranta 56
Lawrence 54
São Paulo 47
Seoul 45
San Diego 43
Chicago 42
Frankfurt am Main 42
Nanjing 41
Toronto 38
Alimena 37
Ludwigshafen am Rhein 31
Orem 29
Amsterdam 28
Helsinki 28
Montreal 28
Nuremberg 28
Redwood City 27
Naples 23
Florence 22
Columbus 21
Dearborn 21
Istanbul 21
Atlanta 20
Brooklyn 20
Phoenix 20
Bologna 19
Halifax 19
Shenyang 18
Washington 18
Brussels 17
Rio de Janeiro 17
Catania 16
Warsaw 16
Bari 15
Johannesburg 15
Shanghai 15
Tianjin 15
Boston 14
Da Nang 14
Kingston 14
Paris 14
Genoa 13
Msida 13
San Francisco 13
Abidjan 12
Central 12
Chennai 12
Denver 12
Kumar 12
Ottawa 12
Venice 12
Baghdad 11
Jiaxing 11
Melbourne 11
Messina 11
Tehran 11
Zhengzhou 11
Amman 10
Erbil 10
Falls Church 10
Jinan 10
Munich 10
Padova 10
Totale 9.141
Nome #
Better social but worse academic premorbid adjustment in cannabis-users psychotic patients across Europe 482
Cannabis consumption and the risk of psychosis 468
Interplay Between Childhood Maltreatment, Subclinical Post-Traumatic Stress Symptoms, and IQ: Findings From the EU-GEI Multicentre Case–Control Study 435
Effetti dell’uso di cannabis e sintomi psicopatologici in un campione di primi episodi psicotici 399
Evaluating the feasibility of the Italian version of the computerized interactive remediation of cognition training for schizophrenia (circuits) 315
Low incidence of psychosis in Italy: confirmation from the first epidemiological study in Sicily 294
Treated incidence of psychotic disorders in the multinational EU-GEI study 277
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU GEI study 271
Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations 269
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study 267
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study 253
Prevalence and Risk Factors for Internet Gaming Disorder (IGD) in a sample of 5,979 Italian Online Gamers 250
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 246
Differences between female and male gamers and gender-specific risk-factors for internet gaming disorder (IGD) 246
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use 239
Cumulative social disadvantage and psychosis: findings from a southern Italy case-control study 238
Premorbid social adjustment is better in cannabis-using than non-using psychotic patients across Europe 238
DOES POLYGENIC RISK SCORE FOR SCHIZOPHRENIA IMPACT ON JUMPING TO CONCLUSIONS? PRELIMINARY FINDINGS FROM THE EU-GEI CASE-CONTROL STUDY 229
INTERNET OUT OF CONTROL: THE ROLE OF SELF-ESTEEM AND PERSONALITY TRAITS IN PATHOLOGICAL INTERNET USE 228
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls 228
Risk factors for internet gaming disorder in a sample of 5,979 italian online gamers. 227
BIOLOGICAL AND EPIDEMIOLOGICAL EXAMINATION OF TRANSDIAGNOSTIC AND SPECIFIC SYMPTOM DIMENSIONS AT PSYCHOSIS ONSET: FINDINGS FROM THE EUGEI STUDY 221
Better IQ but worse Premorbid Academic Adjustment in cannabis-users psychotic patients: another brick in the intuition 220
Psychological distress and suicidal ideation in Sicilian Medical Students: The SMS-ME project 219
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study 219
Are Polygenic Risk Scores for Major Mental Disorders Associated with General or Specific Psychosis Symptom dimensions? 214
IL RICONOSCIMENTO DELLE EMOZIONI FACCIALI NEI DISTURBI PSICOTICI: UNO STUDIO SUI MECCANISMI GENETICI ED EPIGENETICI 211
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 208
Internet addiction e comorbilità psichiatrica 207
F115POLYGENIC RISK SCORES FOR SCHIZOPHRENIA, BIPOLAR, AND MAJOR DEPRESSIVE DISORDERS PREDICT TRANSDIAGNOSTIC SYMPTOM DIMENSIONS AT FIRST EPISODE PSYCHOSIS 206
IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use. 195
What does augment the risk to use cannabis on an everyday-basis in psychotic patients? 190
Working Memory, Jumping to Conclusions and Emotion Recognition: a Possible Link in First Episode Psychosis (Fep) 187
O4.8. CAN YOU SPOT EMOTIONS? FACIAL EMOTION RECOGNITION AND GENETIC RISK FOR PSYCHOSIS 187
Does age of first cannabis use and frequency of use influence age of first-episode psychosis (FEP)? 183
FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS 183
30 Years on: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed into the Developmental Risk Factor Model of Psychosis 182
Perceived stigma in patients affected by psychosis: Is there an impact on relapse? 181
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme 174
DOES CANNABIS USE WORSEN PSYCHOTIC SYMPTOM PRESENTATION? 166
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study 165
Latent burnout profiles in a sample of frontline healthcare professionals after the peak of the Italian COVID-19 pandemic 163
Children and Families' mental health during the first COVID-19 lockdown in Italy 163
The role of different game-genres in predicting internet gaming disorder (IGD) 163
Social disadvantage and psychosis: a case control study on italian First-Episodes of Psychosis (FEP) 158
FIRST EPISODE PSYCHOSIS PATIENTS WHO USED CANNABIS DEVELOP THEIR ILLNESS AT A SIGNIFICANTLY YOUNGER AGE THAN THOSE WHO NEVER USED CONSISTENTLY ACROSS EUROPE AND BRAZIL 155
COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY 148
O3.1. ASSOCIATION OF EXTENT OF CANNABIS USE AND ACUTE INTOXICATION EXPERIENCES IN A MULTI-NATIONAL SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS AND CONTROLS 145
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study 139
CAN PRS FOR SCHIZOPHRENIA, BIPOLAR DISORDER AND MAJOR DEPRESSION DISTINGUISH AFFECTIVE PSYCHOSIS DIAGNOSTIC CATEGORIES? THE EU-GEI STUDY 138
La Cannabis come fattore di rischio per i disturbi psicotici: uno studio su un campione italiano 137
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IMPAIRMENT IN FIRST EPISODE PSYCHOSIS ACROSS EUROPE 137
Lifestyles and Quality of Life of People with Mental Illness During the COVID-19 Pandemic 136
IS THE ERA OF CANDIDATE GENES X CANNABIS USE REALLY DEAD? 135
BEHAVIOURAL PREDICTORS OF WEIGHT LOSS MAINTENANCE AFTER BARIATRIC SURGERY: A SCOPING REVIEW 132
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI) 132
Profilo neuropsicologico dei pazienti al first-episode: variabilità della performance cognitiva tra sintomi positivi e negativi 132
T42. JUMPING TO CONCLUSIONS IS ASSOCIATED WITH THE POLYGENIC RISK SCORE FOR INTELLIGENCE BUT NOT FOR SCHIZOPHRENIA. PRELIMINARY FINDINGS FROM THE EU-GEI STUDY 131
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors 129
What drives the higher incidence of psychosis in London compared to Palermo? 129
SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE 127
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study 124
FIRST EPISODE PSYCHOSIS PATIENTS ACROSS EUROPE DIFFER IN INTELLECTUAL QUOTIENT (IQ) AND EXPOSURE TO ENVIRONMENTAL HAZARDS 118
Tobacco use in first-episode psychosis, a multinational EU-GEI study 112
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IN FIRST-EPISODE PSYCHOSIS: LONGITUDINAL INSIGHTS FROM THE GAP FOLLOW-UP STUDY 112
35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS 111
Migration history and risk of psychosis: Results from the multinational EU-GEI study 106
The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study 106
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data 105
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings 105
Metabolic Syndrome in people treated with Antipsychotics (RISKMet): A multimethod study protocol investigating genetic, behavioural, and environmental risk factors 103
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study 103
EXPLORING SPECIFIC EFFECTS OF TYPE AND TIMING OF EXPOSURE TO CHILDHOOD ADVERSITY AND SYMPTOM DOMAINS IN FIRST EPISODE OF PSYCHOSIS: PRELIMINARY RESULTS FROM THE EUGEI PROJECT 101
Ruolo della working memory e dello stile di risposta Jumping To Conclusions in un campione di pazienti al first episode psychosis 98
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study 97
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study 96
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project 96
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 95
P.0170 Distinct polygenic risk scores in clusters of psychotic subjects with different premorbid trajectories and current IQ 95
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study 93
Profilo neuropsicologico in pazienti al first episode psychosis e nei familiari di primo grado: un'ipotesi di vulnerabilità genetica 92
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study 92
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study 90
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 89
THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE 89
Working memory e jumping to conclusions 87
GENE AND ENVIRONMENT INTERPLAY AMONG DIAGNOSTIC CATEGORIES IN THE EUGEI STUDY 87
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study 86
Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study 84
ENVIRONMENTAL RISK FACTORS DIFFERENCES AMONG DIAGNOSTIC CATEGORIES IN EU-GEI STUDY 83
P.0171 The independent and joint effect of the endocannabinoid system and daily cannabis use on the risk of psychosis 79
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study 78
DNA METHYLATION PROFILING MIGHT SHED LIGHT ON THE BIOLOGY OF CANNABIS ASSOCIATED PSYCHOSIS 78
Methylomic signature of current cannabis use in two first-episode psychosis cohorts 77
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis 75
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study 72
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study 71
SU132CANNABIS USE AND SCHIZOPHRENIA: CAN GENETICS TELL IF IS IT "THE CHICKEN OR THE EGG"? 70
SA11DO PRS FOR SQUIZOPHRENIA, BIPOLAR DISORDER AND MAJOR DEPRESSION DISTINGUISH BETWEEN AFFECTIVE-PSYCHOSIS DIAGNOSTIC CATEGORIES? THE EUGEI STUDY 70
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies 66
Totale 16.437
Categoria #
all - tutte 57.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022972 0 134 27 48 40 77 35 207 81 78 79 166
2022/20231.402 113 224 63 112 123 238 81 114 148 30 127 29
2023/20241.363 35 91 76 193 96 116 127 323 8 55 52 191
2024/20251.967 69 95 97 186 110 76 144 160 209 219 252 350
2025/20266.920 435 200 430 848 635 834 1.002 712 552 504 431 337
2026/2027642 424 218 0 0 0 0 0 0 0 0 0 0
Totale 16.677